skip to primary navigationskip to content

Cambridge Institute for Medical Research

Department A-Z

Our strategy

We aim to create an inspiring environment in which outstanding scientists can excel. By providing state-of-the-art core facilities and support for our researchers, we foster new collaborations that spark discoveries about fundamental cellular processes and their relevance in disease.

Read more

Research advances

In Nature Communications, Rubinsztein and colleagues reveal that selective autophagy-mediated degradation of the Notch receptor in stem cells is important for normal differentiation. When autophagy is reduced, normal development of the mouse brain and gut is delayed.

Read more

Academy of Medical Sciences Fellowship

Many congratulations to David Owen for his election as a new Fellow of the Academy of Medical Sciences.

Read more

FEBS National Lecture Award

Alan Warren will receive a FEBS National Lecture Award at the Austrian Society for Molecular Biology and Biotechnology annual meeting in September. These awards, established to commemorate the 40th anniversary of FEBS, recognize the achievements of distinguished scientists.

Read more

A unique partnership between basic and clinical research, aiming to understand the cellular basis of disease

New publications


Smith lab (PLoS Genet. 2016)

eQTL mapping of immune disease.


Maxwell lab (Sci. Rep. 2016)

Targeting hypoxic cancer cells.


Reid lab (PloS One 2016)

Detecting motor defects in spastin mutants.


Rubinsztein lab (Nature Comm. 2016)

Autophagy control in stem cells.


Ron lab (eLife 2016)

AMPylation of BiP ER chaperone.